ESTRELLA IMMUNOPHARMA, INC. Effective Income Tax Rate Reconciliation, Deduction, Other, Percent
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Effective Income Tax Rate Reconciliation, Deduction, Other, Percent of 21.00% for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-01.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther · last filed 2023-08-01
- ESTRELLA IMMUNOPHARMA, INC. effective income tax rate reconciliation, deduction, other, percent for the quarter ending 2023-06-30 was 21.00%, a 0.00% change year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. effective income tax rate reconciliation, deduction, other, percent for the quarter ending 2022-06-30 was 21.00%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Other, Percent 3 month | Effective Income Tax Rate Reconciliation, Deduction, Other, Percent 6 month |
|---|---|---|
| 2023-06-30 | 21.00% 10-Q · filed 2023-08-01 | 21.00% 10-Q · filed 2023-08-01 |
| 2022-06-30 | 21.00% 10-Q · filed 2023-08-01 | 21.00% 10-Q · filed 2023-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |